Skip to main content

Advertisement

SpringerLink
Log in

The Effect of Inhaled Budesonide and Formoterol on Bronchial Remodeling and HRCT Features in Young Asthmatics

  • ASTHMA
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Asthma is a chronic disease that may cause remodeling of the airways. We aimed to observe the effects of the combined use of inhaled budesonide and formoterol on both the reversibility of remodeling and structural changes in the airways. Thirty-six male patients (age range, 20–31) with mild-to-moderate persistent asthma were given inhaled formoterol and budesonide treatment for three months. Bronchial diameter (BD) and bronchial wall thickness (BWT), as measured by high-resolution computerized tomography, and reticular basement membrane thickness (RBMT), assessed in bronchoscopic biopsy specimens, were compared with pretreatment findings. Twenty-two age-matched male controls were also enrolled. BDs of the patients were significantly smaller than in the controls, whereas BWT and RBMT were greater. After three months BWT and RBMT of the subsegmental airways significantly decreased and BD increased. There was a prominent eosinophilic and lymphocytic infiltration in the bronchial mucosa of the asthmatics, and the eosinophilic infiltration significantly improved with treatment. Both serum total IgE and eosinophil counts were related to eosinophilic infiltration in the biopsy samples (r = 0.494 and r = 0.463, respectively). FEV1 was positively correlated with the diameters of the segmental and subsegmental airways (r = 0.491 and r = 0.265, respectively) and negatively correlated with BWT of the subsegmental airways (r = −0.293) and with the RBMT of both the segmental and subsegmental airways (r = −0.597 and r = −0.590, respectively). We suggest that treatment with inhaled formoterol and budesonide may reverse increased RBMT and BWT as part of remodeling in patients with asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adcock IM, Maneechotesuwan K, Usmani O (2002) Molecular interactions between glucocorticoids and long-acting beta-2 agonists. J Allergy Clin Immunol 110:S261–S268

    Article  PubMed  CAS  Google Scholar 

  2. Awadh N, Muller NL, Park CS, Abboud RT, FitzGerald JM (1998) Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed scanning. Thorax 53:248–253

    PubMed  CAS  Google Scholar 

  3. Barbato A, Turato G, Baraldo S, et al. (2003) Airway inflammation in childhood asthma. Am J Respir Crit Care Med 168:798–803

    Article  PubMed  Google Scholar 

  4. Boulet LP, Turcotte H, Laviolette M, et al. (2000) Airway hyperresponsiveness, inflammation and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Am J Respir Crit Care Med 162:1308–1313

    PubMed  CAS  Google Scholar 

  5. Bousquet J, Jeffery PK, Busse WW, et al. (2000) Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720–1745

    PubMed  CAS  Google Scholar 

  6. Bumbacea D, Campbell D, Nguyen L, et al. (2004) Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 24:8–10

    Article  Google Scholar 

  7. Chetta A, Foresi A, Del Donno M, et al. (1997) Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852–857

    PubMed  CAS  Google Scholar 

  8. Djukanovic R, Wilson JW, Britten KM, et al. (1992) Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145:669–674

    PubMed  CAS  Google Scholar 

  9. Eickelberg O, Roth M, Lorx R, et al. (1999) Ligand-independent activation of the glucocorticoid receptor by the beta-2 adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 274:1005–1010

    Article  PubMed  CAS  Google Scholar 

  10. Fish JE, Peters SP (1999) Asthma severity: histopathologic correlations. Drugs Today 35:585–594

    PubMed  CAS  Google Scholar 

  11. Gono H, Fujimoto K, Kawakami S, Kubo K (2003) Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma. Eur Respir J 22:965–971

    Article  PubMed  CAS  Google Scholar 

  12. Hadcock JR, Wang H-Y, Malbon CC. (1989) Agonist-induced destabilization of beta adrenergic receptor mRNA: attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem 264:19928–19933

    PubMed  CAS  Google Scholar 

  13. Hoshino M, Nakamura Y, Sim JJ, et al. (1998) Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-1 expression in bronchial asthma. Clin Exp Allergy 28:568–577

    Article  PubMed  CAS  Google Scholar 

  14. Hoshino M, Takahashi M, Takai Y, et al. (1999) Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 104:356–363

    Article  PubMed  CAS  Google Scholar 

  15. Hudon C, Turcotte H, Laviolette M, Carrier C, Boulet LP (1997) Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol 78:195–202

    PubMed  CAS  Google Scholar 

  16. James AL, Maxwell PS, Pearce-Pinto G, Elliot JG, Carrol NG (2002) The relationship of reticular basement membrane thickness to airway wall remodeling in asthma. Am J Respir Crit Care Med 166:1590–1595

    Article  PubMed  Google Scholar 

  17. Jeffery PK, Godfrey RW, Adelroth E, et al. (1992) Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 145:890–899

    PubMed  CAS  Google Scholar 

  18. Kasahara K, Shiba K, Ozawa T, et al. (2002) Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 57:242–246

    Article  PubMed  CAS  Google Scholar 

  19. King GG, Muller NL, Whittal KP, Xiang QS, Pare PD (2000) An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. Am J Respir Crit Care Med 161: 574–580

    PubMed  CAS  Google Scholar 

  20. Koshak EA, Alamoudi OS (1999) Do eosinophil counts correlate differently with asthma severity by symptoms versus peak flow rate? Ann Allergy Asthma Immunol 83:567–571

    Article  PubMed  CAS  Google Scholar 

  21. Koto HM, Mak JCW, Haddad E-B, et al. (1996) Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1-beta in vivo in the rat. J Clin Invest 98:1780–1787

    PubMed  CAS  Google Scholar 

  22. Laitinen A, Karjalainen E-M, Altraja A, et al. (2000) Histopathologic features of early and progressive asthma. J Allergy Clin Immunol 105(2 Pt 2):S509–S513

    Article  PubMed  CAS  Google Scholar 

  23. Laprise C, Laviolette M, Boutet M, et al. (1999) Asymptomatic airway hyperesponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 14:63–73

    Article  PubMed  CAS  Google Scholar 

  24. Lee YM, Park JS, Hwang JH, et al. (2004) High resolution CT findings in patients with near-fatal asthma. Comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 126:1840–1848

    Article  PubMed  Google Scholar 

  25. Lloyd CM, Gonzalo JA, Nguyen T, et al. (2001) Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol 166:2033–2040

    PubMed  CAS  Google Scholar 

  26. Louis R, Lau LCK, Bron AO, et al. (2000) The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161:9–16

    PubMed  CAS  Google Scholar 

  27. Lundgren R, Soderberg M, Horstedt P, et al. (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1:883–889

    PubMed  CAS  Google Scholar 

  28. Mak JCW, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ (1995) Protective effect of a glucocorticoid on downregulation of pulmonary beta-2 adrenergic receptors in vivo. J Clin Invest 96:99–106

    Article  PubMed  CAS  Google Scholar 

  29. McMillan SJ, Xanthout G, Lloyd CM (2005) Therapeutic administration of budesonide ameliorates allergen-induced airway remodeling. Clin Exp Allergy 35:388–396

    Article  PubMed  CAS  Google Scholar 

  30. Nakano Y, Müller NL, King GG, et al. (2002) Quantitative assessment of airway remodeling using high-resolution CT. Chest 122:271–275

    Article  Google Scholar 

  31. Neville RG, Pearson MG, Richards N, et al. (1999) A cost analysis on the pattern of asthma prescribing in the UK. Eur Respir J 14:605–609

    Article  PubMed  CAS  Google Scholar 

  32. Olivieri D, Chetta A, Del Donno M, et al. (1997) Effects of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 155:1864–1871

    PubMed  CAS  Google Scholar 

  33. Overbeek SE, Mulder PG, Baelemans SM, Hoogsteden HC, Prins JB (2005) Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. Chest 128:1121–1127

    Article  PubMed  CAS  Google Scholar 

  34. Paganin F, Seneterre E, Chanez P, et al. (1996) Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 153: 110–114

    PubMed  CAS  Google Scholar 

  35. Saetta M, Maestrelli P, Turato G, et al. (1995) Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 151:489–494

    PubMed  CAS  Google Scholar 

  36. Serrano J, Plaza V, Sanchis J (1999) Hospital admission from asthma. A descriptive study and analysis of factors related to prognosis after release. Arch Bronchopneumol 35:372–378

    CAS  Google Scholar 

  37. Sont JK, Willems LNA, Bel EH, et al. (1999) Clinical control and histopathologic outcome of asthma when using airway hyperesponsiveness as an additional guideline to long-term treatment. Am J Respir Crit Care Med 159:1043–1051

    PubMed  CAS  Google Scholar 

  38. Trigg CJ, Manolitsas ND, Wang J, et al. (1994) Placebo-controlled immunopathologic study of 4 months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 150:17–22

    PubMed  CAS  Google Scholar 

  39. Usmani OS, Maneechotesuwan K, Adcock IM, Barnes PJ (2002) Glucocorticoid receptor activation following inhaled fluticasone and salmeterol (abstract). Am J Respir Crit Care Med 165:A616

    Google Scholar 

  40. Vignola AM, Paganin F, Capieu L, et al. (2004) Airway remodeling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 24:893–894

    Article  Google Scholar 

  41. Vignola AM, Riccobono L, Profita M, et al. (2005) Effects of low doses of inhaled fluticasone propionate on inflammation and remodeling in persistent-mild asthma. Allergy 60:1511–1517

    Article  PubMed  CAS  Google Scholar 

  42. Wallin A, Sandstrom T, Soderberg M, et al. (1999) The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 159:79–86

    PubMed  CAS  Google Scholar 

  43. Ward C, Pais M, Bish R, et al. (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57:309–316

    Article  PubMed  CAS  Google Scholar 

  44. Ward C, Walters H (2005) Airway remodeling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 5: 43–48

    Article  PubMed  CAS  Google Scholar 

  45. Wilson JW, Li X (1997) The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 27:363–371

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GATA Camlica Gogus Hastaliklari Hastanesi, Acibadem Caddesi, Uskudar, Istanbul, 34660, Turkey

    Firuz Capraz, Erdogan Kunter, Hakan Cermik, Ahmet Ilvan & Suheyl Pocan

Authors
  1. Firuz Capraz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erdogan Kunter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Cermik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmet Ilvan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suheyl Pocan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erdogan Kunter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capraz, F., Kunter, E., Cermik, H. et al. The Effect of Inhaled Budesonide and Formoterol on Bronchial Remodeling and HRCT Features in Young Asthmatics. Lung 185, 89–96 (2007). https://doi.org/10.1007/s00408-006-0007-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-006-0007-2

Keywords

Search

Navigation